Updated:
PDL BIOPHARMA, INC.
PDL BIOPHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000882104, and its reported industry is...
Overview
PDL BIOPHARMA, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000882104, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2020-03-11, it reported annual revenue of USD 54,757,000; net income of USD -70,411,000; total assets of USD 716,119,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- PDL BIOPHARMA, INC.
- Former names in filing history
- PROTEIN DESIGN LABS INC/DE (1994-02-14 to 2006-01-19)
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Reno, NV, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0000882104
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2019USD | $54.8M | -$70.4M | $716.1M | $193.5M | -$32.4M | |
| FY2018USD | $198.1M | -$68.9M | $963.7M | $394.6M | -$13.4M | |
| FY2017USD | $320.1M | $110.7M | $1.2B | $527.3M | $40.6M | |
| FY2016USD | $244.3M | $63.6M | $1.2B | $147.2M | $101.7M |
FY2019. Revenue, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2018. Revenue, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2017. Revenue: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-K | 10-K | ||
| SC 13D | — | Form SC 13D | |
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research PDL BIOPHARMA, INC. in Altss
Track this company’s investors, transactions and relationships in Altss.